SLC6A1 and prostate carcinoma: To assess the effects of SLC6A1 in aggressive features of prostate cancer cells, we established stable cell lines PC3 and LNCaP with the overexpressed orthe reduced expression of SLC6A1 following the transfection of the expression vector or the specific shRNA, respectively.